Search research articles
Contact Us
Filters
Showing results (111-120 of 165) with videos related to
Page
of 17
Sort By:
Bone Marrow Transplantation
|
October 7, 2022
Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia
Arnon Nagler, Christophe Peczynski, Bhagirathbhai Dholaria, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2021
Comparison Between 5-Azacytidine Treatment and Allogeneic Stem-Cell Transplantation in Elderly Patients With Advanced MDS According to Donor Availability (VidazaAllo Study)
Nicolaus Kröger, Katja Sockel, Christine Wolschke, et al.
Bone Marrow Transplantation
|
July 30, 2020
Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMT
Arnon Nagler, Frédéric Baron, Myriam Labopin, et al.
American Journal of Hematology
|
December 6, 2025
Non-T-Depleted Haploidentical Transplantation Compared to Allogeneic Transplantation From Matched Siblings or Unrelated Donors in Patients With Secondary AML in First Complete Remission: A Study From the ALWP/EBMT
Arnon Nagler, Sarah Kayser, Allain Thibeault Ferhat, et al.
European Journal of Haematology
|
June 3, 2025
Sensitization of Non-M3 Acute Myeloid Leukemia Blasts to All-Trans Retinoic Acid by the LSD1 Inhibitor Tranylcypromine: TRANSATRA Phase I Study
Michael Kruszewski, Claudia Schmoor, Tobias Berg, et al.
Bone Marrow Transplantation
|
December 20, 2024
Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party
Jesús Duque-Afonso, Jürgen Finke, Maud Ngoya, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 19, 2019
Biology-Driven Approaches to Prevent and Treat Relapse of Myeloid Neoplasia after Allogeneic Hematopoietic Stem Cell Transplantation
Robert Zeiser, Dietrich W Beelen, Wolfgang Bethge, et al.
Annals of Hematology
|
April 5, 2017
Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial
Friederike Braulke, Xenia Schulz, Ulrich Germing, et al.
Cancer
|
May 25, 2022
Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia
Justin Loke, Myriam Labopin, Charles Craddock, et al.
Haematologica
|
February 4, 2021
Efficacy of UVC-treated, pathogen-reduced platelets versus untreated platelets: a randomized controlled non-inferiority trial
Veronika Brixner, Gesine Bug, Petra Pohler, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 165) with videos related to
Sort By:
Page
of 17
Bone Marrow Transplantation
|
October 7, 2022
Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia
Arnon Nagler, Christophe Peczynski, Bhagirathbhai Dholaria, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2021
Comparison Between 5-Azacytidine Treatment and Allogeneic Stem-Cell Transplantation in Elderly Patients With Advanced MDS According to Donor Availability (VidazaAllo Study)
Nicolaus Kröger, Katja Sockel, Christine Wolschke, et al.
Bone Marrow Transplantation
|
July 30, 2020
Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMT
Arnon Nagler, Frédéric Baron, Myriam Labopin, et al.
American Journal of Hematology
|
December 6, 2025
Non-T-Depleted Haploidentical Transplantation Compared to Allogeneic Transplantation From Matched Siblings or Unrelated Donors in Patients With Secondary AML in First Complete Remission: A Study From the ALWP/EBMT
Arnon Nagler, Sarah Kayser, Allain Thibeault Ferhat, et al.
European Journal of Haematology
|
June 3, 2025
Sensitization of Non-M3 Acute Myeloid Leukemia Blasts to All-Trans Retinoic Acid by the LSD1 Inhibitor Tranylcypromine: TRANSATRA Phase I Study
Michael Kruszewski, Claudia Schmoor, Tobias Berg, et al.
Bone Marrow Transplantation
|
December 20, 2024
Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party
Jesús Duque-Afonso, Jürgen Finke, Maud Ngoya, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 19, 2019
Biology-Driven Approaches to Prevent and Treat Relapse of Myeloid Neoplasia after Allogeneic Hematopoietic Stem Cell Transplantation
Robert Zeiser, Dietrich W Beelen, Wolfgang Bethge, et al.
Annals of Hematology
|
April 5, 2017
Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial
Friederike Braulke, Xenia Schulz, Ulrich Germing, et al.
Cancer
|
May 25, 2022
Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia
Justin Loke, Myriam Labopin, Charles Craddock, et al.
Haematologica
|
February 4, 2021
Efficacy of UVC-treated, pathogen-reduced platelets versus untreated platelets: a randomized controlled non-inferiority trial
Veronika Brixner, Gesine Bug, Petra Pohler, et al.
Page
of 17